Log In
Monday 26th August 2019

New drug to prevent blood clots

30th November 2011

New draft guidance from the National Institute for Health and Clinical Excellence (NICE) could see patients who undergo hip and knee surgery receiving a new drug called apixaban (brand name Eliquis) to reduce their risk of life-threatening blood clots.

Hip and knee replacement surgery is known to carry an increased risk of venous thromboembolism (VTE), which occurs when a blood clot forms in one of the deep veins of the body and NICE has now said apixaban may be considered as an option for these patients.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019